Related Experiment Video
Updated: May 5, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
ALKBH5 regulates key lipid metabolites to promote osteoporosis
1Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Abstract:
Osteoporosis is a prevalent metabolic bone disease. Research has found a link between N6-methyladenosine (m6A) methylation and bone metabolism. The aim of this study is to investigate the relationship between m6A methylation modification-related genes and osteoporosis, and to explore the role of plasma metabolites in this relationship. Exposure was determined using cis-expression quantitative trait loci from the expression quantitative trait locus gen consortium, and a two-sample Mendelian randomization (MR) approach was employed to analyze the causal relationship between m6A methylation-related genes and osteoporosis. Summary-data-based Mendelian randomization (SMR) analysis was conducted to enhance the reliability of the Mendelian randomization results. Using the single-cell expression quantitative trait loci dataset, we explored the relationship between m6A methylation-related genes and osteoporosis in 14 types of immune cells. Mediation analysis was performed to investigate the effects of plasma metabolites and AlkB Homolog 5 (ALKBH5) on osteoporosis. Our study identified a causal association between the ALKBH5 gene and osteoporosis (odds ratio [OR] = 1.2742, 95% confidence interval: 1.1492-1.4128, P < .05). Moreover, this relationship persists in dendritic cells (OR = 1.5527, 95% confidence interval: 1.1838-2.0365, P < .05). The levels of 1-(1-enyl-palmitoyl)-GPE (P-16:0) and the ratio of Benzoate to oleoyl-linoleoyl-glycerol (18:1 to 18:2) [2] play a mediating role in the relationship between ALKBH5 and osteoporosis, with mediation effects accounting for 15.1% and 8.7% of the total effect, respectively. These results reveal a potential link between m6A methylation-related genes and osteoporosis, providing new evidence for the investigation of pathogenic mechanisms and the exploration of therapeutic targets.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Skeleton and Calcium Homeostasis